Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage

ConclusionsTreatment with repeated low-dose rhEPO improved outcomes in preterm infants with IVH.Trial RegistrationThe study was retrospectively registered on ClinicalTrials.gov on 16 April 2019 (NCT03914690).

Source: CNS Drugs - May 6, 2021 Category: Neurology Source Type: research